    Mary Szela | Abbott Laboratories company | ZoomInfo.com    Mary Szela | Abbott Laboratories company | ZoomInfo.com

Mary Szela, Novelion Therapeutics Inc: Profile & Biography - Bloomberg


































































  


























Feedback





Mary Szela

Chief Executive Officer,
Novelion Therapeutics Inc






Career History




Chief Executive Officer
Novelion Therapeutics Inc, 12/2016-PRESENT


Chief Executive Officer
Aegerion Pharmaceuticals Inc, 1/2016-11/2016


Chief Executive Officer
Melinta Therapeutics, 10/2013-2015


Chief Executive Officer
Rib-X Pharmaceuticals Inc, 4/2013-10/2013


Senior VP:Global Strategic Mktg
Abbott Laboratories Inc, 1/2010-5/2012


Senior VP:US Pharmaceuticals
Abbott Laboratories Inc, 9/2008-12/2009


Senior VP:Pharmaceutical Ops
Abbott Laboratories Inc, 2007-2008


VP:Pharmaceutical Operations
Abbott Laboratories Inc, 2006-2006


VP:Pharmaceutical Products
Abbott Laboratories Inc, 2001-2006


VP:Hospital Products Business
Abbott Laboratories Inc, 1998-2001


Show More









Website:
www.novelion.com






Corporate Information
Address:

887 Great Northern Way
Suite 250
Vancouver, BC V5T 4T5
Canada


Phone:
1-877-764-3131


Fax:
1-604-707-7001


Web url:
www.novelion.com











From The Web












Personal Information



Education



University of Illinois
Bachelor's Degree, Nursing, 1991


University of Illinois
MBA, 1991








Memberships



Board Memberships




Novelion Therapeutics Inc


Board Member, 12/2016-PRESENT




Coherus Biosciences Inc


Board Member, 7/2014-PRESENT




Suneva Medical Inc


Board Member, 7/2012-PRESENT




Novo Nordisk A/S


Board Member, 3/2015-5/2017




Aegerion Pharmaceuticals Inc


Board Member, 1/2016-11/2016




Receptos Inc


Board Member, 7/2014-8/2015




Rib-X Pharmaceuticals Inc


Chairman, 1/2013-UNKNOWN



Show More








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data


































Mary T. Szela: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 6:45 PM ET
Biotechnology

Company Overview of Novelion Therapeutics Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Mary T. Szela  Chief Executive Officer and Director, Novelion Therapeutics Inc.AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 9 different industries.See Board Relationships54$7,410,556As of Fiscal Year 2016
Background

		Ms. Mary T. Szela has been the Chief Executive Officer of Novelion Therapeutics Inc. since November 29, 2016. Ms. Szel served as the Chief Executive Officer of Aegerion Pharmaceuticals, Inc. from January 07, 2016 to November 29, 2016. Ms. Szela served as the Chief Executive Officer of Melinta Therapeutics, Inc. from April 3, 2013 to August 2015, Chairperson since January 4, 2013 and also served as its President. Ms. Szela served as a Senior Vice President of Global Strategic ... Marketing and Services at Abbott Diabetes Care, Inc. since January 2010. Ms. Szela served as a Senior Vice President of Global Strategic Marketing and Services Pharmaceutical Products Group at Abbott Laboratories since 2010 and also served as its Senior Vice President of U S Pharmaceuticals from 2008 to 2009. She served more than two decades in senior roles at Abbott Laboratories. She served as Senior Vice President, U.S. Pharmaceuticals. at Abbott Diabetes Care, Inc. She served as Senior Vice President of Pharmaceutical Operations of Abbott's commercial pharmaceutical business in the United States from August 2007 to 2008. She served as Corporate Officer at Abbott Laboratories since 2001. She served as Vice President of Commercial Pharmaceutical Operations at Abbott Laboratories since 2006, where she was responsible for sales and marketing of many of Abbott's pharmaceutical brands, including HUMIRA. She served as Vice President of Pharmaceutical Products, Primary Care Operations of Abbott Laboratories from 2001 to 2006. She joined Abbott in 1987 and has held several leadership positions at Abbott, including Divisional Vice President of Hospital Products Business Sector from 1998 to 2001. She served as General Manager of Anesthesia, Hospital Products since 1998. She worked for the University of Illinois Hospital. She served as the Chairperson of Rib-X Pharmaceuticals, Inc. since January 4, 2013 and has been its Director since January 4, 2013. She has been a Director of Novelion Therapeutics Inc. since November 29, 2016. She has been a Director of Coherus Biosciences, Inc. since July 2014. She has been a Director at Aegerion Pharmaceuticals, Inc., since January 07, 2016. She has been Director of Arisaph Pharmaceuticals, Inc. since 2007. She serves as a Director of Suneva Medical, Inc. She served as Director of Novo Nordisk A/S from March 19, 2015 to May 16, 2017. She served as a Director of Melinta Therapeutics, Inc. since January 4, 2013. She served as a Director of Receptos, Inc. from July 2014 to August 27, 2015. Ms. Szela earned a Bachelor's degree in Nursing in 1985 and a Master's degree in Business Administration in 1991 from the University of Illinois.Read Full Background




Corporate Headquarters
887 Great Northern WayVancouver, British Columbia V5T 4T5CanadaPhone: 604-707-7000Fax: 604-707-7001
Board Members Memberships
DirectorSuneva Medical, Inc.2007-PresentDirectorArisaph Pharmaceuticals, Inc.2014-PresentDirectorCoherus Biosciences, Inc.2016-PresentChief Executive Officer and DirectorNovelion Therapeutics Inc.
Education
Bachelor's Degree 1985University of Illinois-Urbana-ChampaignMBA 1991University of Illinois-Urbana-Champaign
Other Affiliations
Abbott LaboratoriesNovo Nordisk A/SMelinta Therapeutics, Inc.University of Illinois-Urbana-ChampaignArisaph Pharmaceuticals, Inc.Aegerion Pharmaceuticals, Inc.Suneva Medical, Inc.Receptos, Inc.Coherus Biosciences, Inc.


Annual Compensation
Salary$679,973Total Annual Compensation$679,973
Stocks Options
Restricted Stock Awards$1,723,618All Other Compensation$197,973Unexercisable Options$323,520Total Number of Options$323,520
Total Compensation
Total Annual Cash Compensation$1,204,396Total Short Term Compensation$679,973Other Long Term Compensation$1,921,591Total Calculated Compensation$7,410,556




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Novelion Therapeutics Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close



































Mary T. Szela - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Mary T. Szela
Former Dir. and Chief Executive Officer at Novelion Therapeutics Inc.


View Full Profile
Are you Mary T. Szela? Claim your profile


 


Sign up for Equilar Atlas and view Mary T. Szela's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Mary T. Szela's  network and community.
												FOLLOW changes in Mary T. Szela's employment and money-in-motion.
												CONNECT with Mary T. Szela through your network of contacts.
												








Mary T. Szela's Executive Work History


Past
To view Mary T. Szela's complete executive work history, sign up now
Age
54

 
 


Mary T. Szela's Biography




			Chief executive officer of Novelion Therapeutics Inc., US. Member of the Board of Novo Nordisk A/S and the Remuneration Committee since 2015.

Management duties: Member of the boards of Coherus Biosciences, Inc., Novelion Therapeutics Inc. and Suneva Medical Inc., all in the US. Special competences: In-depth understanding of the clinical, regulatory and marketing aspects of the pharmaceutical industry in North America, having both operational and strategic experience.

Education: MBA (1991) from the University of Illinois at Chicago, US, and BSc nursing degree (1985) from the University of Illinois at Chicago, US.
		
Source: Novo Nordisk A/S on 05/01/2017
		
	

 






Sign up for Equilar Atlas and view Mary T. Szela's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Mary T. Szela. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Mary T. Szela's  network and community.
												FOLLOW changes in Mary T. Szela's employment and money-in-motion.
												CONNECT with Mary T. Szela through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Mary T. Szela


















Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft













Mary T. Szela of Coherus BioSciences Inc Board of Directors

















 












Welcome!















Company News
Company Site
Premium
Log In


 



















Membership
Home
Portfolio
Stocks
Bonds
Funds
ETFs
CEF
Markets
Tools
Real Life Finance
Discuss





Investing Ideas


Fund Analyst Picks
Picks by Category
Fund Pick Performance
Picks & Pans E-Newsletter
Fund Spy Column
Fund Spy Book
Bond Squad
Fund Video Reports
FundInvestor Newsletter
ETF Investing
Fund Family Experts



Fund Reports


All Fund Analyst Reports
Fund Stewardship Reports



Fund Ratings


Highest-Rated Value
Highest-Rated Growth
Highest-Rated Large-Cap
Highest-Rated Mid-Cap
Highest-Rated Small-Cap
Foreign Fund Standouts
Star Rating Performance
Rating Methodology



Fund Performance


Top 1-Month Performers
Top YTD Performers
Top 1-Year Performers
Top 3-Year Performers
Top 5-Year Performers
Fund Category Returns
Biggest Daily NAV Changes
Closed-End Funds
Exchange-Traded Funds
Quarterly Market Outlook



Fund Screeners


Basic Screeners
Fund Screener
Long-Term Winners
Solid Small-Growth Funds
Conservative Bond Funds

Premium Screeners
Premium Fund Screener
Index Funds
Hidden Gems
Lower-Risk Foreign Funds


Video Center
 
 

 



 



Coherus BioSciences Inc
 CHRS


Add to PortfolioGet E-mail AlertsPrint This PagePDF ReportData QuestionQuoteChartStock AnalysisPerformanceKey RatiosFinancialsValuationInsidersOwnershipFilingsBondsOverviewExecutive CompensationInsider ActivityKey ExecutivesBoard of DirectorsCommittees
 


Board of Directors
                > Mary T. Szela
            
Mary T. Szela, Independent Director



Profile
Connections






Biography



    Mary T. Szela, age 53, has served as a member of our board of directors since July 2014. In January 2016, Ms. Szela was named Chief Executive Officer of Aegerion Pharmaceuticals, Inc. and served on its board of directors. In November 2016, Aegerion Pharmaceuticals, Inc. merged with QLT Inc. to form Novelion Therapeutics Inc., where Ms. Szela was named Chief Executive Officer and currently serves on its board of directors. Ms. Szela served as the Chief Executive Officer of Melinta Therapeutics, Inc., an antibiotic development company, from April 2013 to August 2015. She also served on the board of directors of Melinta from January 2013 to August 2015. Ms. Szela has served as a member of the boards of directors of Novo Nordisk since March 2015 and Suneva Medical, Inc. since July 2012. She served as a member of the board of directors of Receptos, Inc. from June 2014 to July 2015. Previously, Ms. Szela joined Abbott Laboratories in 1987 and held several leadership positions, including Senior Vice President of Global Strategic Marketing from January 2010 to May 2012 and Senior Vice President of U.S. Pharma ceuticals from September 2008 to December 2009. Prior to Abbott, Ms. Szela worked for the University of Illinois Hospital. Ms. Szela earned a B.S. in Nursing and an M.B.A. from the University of Illinois. We believe Ms. Szela is qualified to serve on our board of directors because of her extensive management experience and expertise in pharmaceutical company operations.
    





Board Membership



Company Name
Board Member Since
Board Committees







Novo Nordisk A/S
-
BOARD,NOMINATION,REMUNERATION







Novelion Therapeutics Inc
-
BOARD







Mary T. Szela is connected to 20 Board Members.See list of all Board Connections.

 


  







We value your feedback. Let us know what you think.













 


Site Directory
Site Map
Our Products












 



 



 




Corrections
Help
Advertising Opportunities
Licensing Opportunities
Glossary
RSS
Mobile Portfolio
Affiliate
Careers 
 


International Sites:
        	Australia
Canada
China
France
Germany
Hong Kong
Italy
The Netherlands
Norway
Spain
U.K.
Switzerland

 




Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry



Premium Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Premium Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



Premium ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Popular Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Popular Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry




Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.
        © Copyright  Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. Russell 2000 quote is 10 minutes delayed.
 


 













 






Mary Szela, CEO, Melinta Pharmaceuticals


























&timesJavascript is disabled
























Market Profiles



Login
Sign up



Login


Sign up








 







 Edit

Person













Mary Szela



CEO
at
Melinta Pharmaceuticals


Location: Chicago, MA





Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop









Mary Szela



CEO
at
Melinta Pharmaceuticals


Location: Chicago, MA




Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop




Mary Szela works as Chief Executive Officer at Melinta Therapeutics. She serves as its President and served as its Chairperson since January 2013. Ms. Szela has been Senior Vice President of Global Strategic Marketing and Services at Abbott Diabetes Care, Inc. since January 2010. Ms. Szela served as a Senior Vice President of Global Strategic Marketing and Services Pharmaceutical Products Group at Abbott Laboratories since 2010 and also served as its Senior Vice President of U S Pharmaceuticals from 2008 to 2009. Ms. Szela served more than two decades in senior roles at Abbott Laboratories. Ms. Szela served as Senior Vice President, U.S. Pharmaceuticals. at Abbott Diabetes Care, Inc. She served as Senior Vice President of Pharmaceutical Operations of Abbott’s commercial pharmaceutical business in the United States from August 2007 to 2008. She served as Corporate Officer at Abbott Laboratories since 2001. She served as Vice President of Commercial Pharmaceutical Operations at Abbott Laboratories since 2006, where she was responsible for sales and marketing of many of Abbott’s pharmaceutical brands, including HUMIRA. Ms. Szela served as Vice President of Pharmaceutical Products, Primary Care Operations of Abbott Laboratories from 2001 to 2006. Ms. Szela joined Abbott in 1987 and has held several leadership positions at Abbott, including Divisional Vice President of Hospital Products Business Sector from 1998 to 2001. She served as General Manager of Anesthesia, Hospital Products since 1998. Ms. Szela worked for the University of Illinois Hospital. She served as the Chairperson of Rib-X Pharmaceuticals, Inc. since January 2013 and has been its Director since January 2013. She has been a Director of Coherus Biosciences Inc. since July 2014 and Novo Nordisk A/S since March 19, 2015. She has been a Director of Arisaph Pharmaceuticals, Inc. since 2007 and Receptos, Inc. since July 2014. She has been a Director of Melinta Therapeutics, Inc. since January 2013. She serves as a Director of Suneva Medical, Inc.



3

Companies in Career





N/A

Related Markets





N/A

Colleagues





N/A

Related Investments








Alias
N/A



Industry
Pharmaceuticals




Tags
Pharmaceutical Industry, Sales Effectiveness, Product Launch, Pharmaceutical Sales




Topics of Influence












Web Site







Blog




































Careers








Achievements








Investments








Related People






 Edit
View all 



Mary SzelaCareer (3)






Sep-2014




Coherus Biosciences



Board Member







May-2014




Receptos



Board Member







Jan-2013




Melinta Pharmaceuticals



CEO








Competencies










 Edit
View all 



Mary SzelaEducation (2)










University of Illinois at Chicago


Administration, Business






1985



University of Illinois at Chicago


Nursing, Masters of Business Administration









 Edit



Mary SzelaAchievements and Recognitions





Add Milestone


No milestones has been recorded for Mary Szela






 Edit



Mary SzelaLinks





Add Link


No links has been recorded for Mary Szela









Mary SzelaInvestments/Acquisitions





No investments has been recorded for Mary Szela









Mary SzelaInvestments Representing Others





No investment reps has been recorded for Mary Szela








Mary SzelaRelated People







View all 
Peers (25)







Robin Bellas

Partner of Lightstone Ventures









Jean-François Formela

Partner of Atlas Venture









Fred  Destin

Partner of Accel Partners









Beth Seidenberg

Partner of KPCB









Dana Mead

Partner of KPCB









Robert Weigle

CEO of Benvenue Medical












View all 



Mary SzelaRecommended Market Profiles (8)








Telemedicine

10,000 or More employees
19 companies








Social Media Marketing (ChiefMartec.com)

5,000 - 10,000 employees
111 companies








Big Data Universe List of Lists

10,000 or More employees
533 companies








Aggregated Marketing Technology

10,000 or More employees
2650 companies








Shared Economy Landscape (Jeremiah Owyang)

10,000 or More employees
267 companies








Inside Sales Landscape

10,000 or More employees
650 companies


















Mary T. Szela, Sr. VP - Pharmaceutical Operations, Abbott Laboratories














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of Mary Szela 





 


Mary Szela

 

Sr. VP - Pharmaceutical Operations - Abbott Laboratories

 


Mary Szela Email :
Please login 

 

Company Name : 
Abbott Laboratories 

 

Company Website : 
www.abbott.com 

 

Company Address : 
100 Abbott Pk. Rd., Abbott Park, IL,United States, 


 


Mary Szela Profile :
Sr. VP - Pharmaceutical Operations - Abbott Laboratories 

 


Mary Szela Biography :


Mary Szela is senior vice president, Pharmaceutical Operations, leading Abbott’s commercial pharmaceutical business in the United States. She was appointed to this position in August 2007.Previously, she served as vice president, Commercial Pharmaceutical Operations, where she was responsible for sales and marketing of many of Abbott's pharmaceutical brands, including HUMIRA.Szela joined Abbott in 1987 and has held several leadership positions at Abbott, including vice president, Primary Care Commercial Operations; and Vice President of Hospital Business sector, responsible for anesthesia, acute care cardiovascular and pain management pharmaceuticals in Abbott's Hospital Products business (now Hospira).Prior to joining Abbott, Szela worked for the University of Illinois Hospital.Szela earned a bachelor's degree in nursing and a master's degree in business administration from the University of Illinois.

 


Mary Szela Colleagues :





Name 
Title 
Email 


David Owen 
Board Dir. 
Please login 


Laura Schumacher 
Exec. VP, General Counsel, Sec. 
Please login 


William Daley 
Board Dir. 
Please login 


John Landgraf 
Sr. VP - Global Pharmaceutical Manufacturing, Supply 
Please login 


Richard Gonzalez 
Dir., Pres., COO 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.



